- Home
- ZTS vs XYL Comparison
ZTS vs XYL Comparison
Compare ZTS & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZTS | XYL |
|---|---|---|
| Founded | 1952 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9B | 26.0B |
| IPO Year | 2012 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ZTS | XYL |
|---|---|---|
| Price | $76.97 | $120.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $154.18 | $152.50 |
| AVG Volume (30 Days) | ★ 4.6M | 1.8M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.86% | 1.49% |
| EPS Growth | ★ 10.05 | 7.40 |
| EPS | ★ 1.42 | 0.79 |
| Revenue | ★ $9,467,000,000.00 | $9,035,000,000.00 |
| Revenue This Year | $5.63 | $2.79 |
| Revenue Next Year | $4.77 | $4.49 |
| P/E Ratio | ★ $53.09 | $151.58 |
| Revenue Growth | 2.28 | ★ 5.52 |
| 52 Week Low | $71.47 | $105.29 |
| 52 Week High | $160.48 | $154.27 |
Technical Indicators
Market Signals| Indicator | ZTS | XYL |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 56.31 |
| Support Level | $73.39 | $115.88 |
| Resistance Level | $78.02 | $120.49 |
| Average True Range (ATR) | 1.96 | 2.64 |
| MACD | 0.49 | -0.45 |
| Stochastic Oscillator | 83.30 | 46.51 |
Price Performance
Historical ComparisonAbout ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
About XYL Xylem Inc. New
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $9 billion in revenue in 2025.